Mr. Patrick T. Higgins

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
  Published on: 11/10/2008    Last Visited: 11/10/2008  

  "The combination of oral antiviral therapies for HCV represents an exciting step in the evolution of HCV treatment," stated Patrick Higgins, Executive Vice President of Marketing and Sales at Pharmasset.

• 
  www.biospace.com/news_story.aspx?NewsEntityId=78546 - [Cached Version]
  Published on: 11/26/2007    Last Visited: 11/27/2007  

  PRINCETON, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Pharmasset, Inc. appointed Patrick T. Higgins as Executive Vice President, Marketing & Sales, responsible for coordinating the global product launch and marketing activities for Pharmasset's drug candidates.Mr. Higgins, who has served as a consultant to Pharmasset since 2006, was recently Vice President, Sales & Marketing, Virology at Hoffmann-LaRoche, Inc.His areas of expertise include hepatology, HIV and cytomegalovirus for transplant patients.Mr. Higgins was responsible for directing the development and implementation of marketing and sales plans for Roche's US hepatology franchise, including the global launch of Pegasys(R) and Copegus(R) for the treatment of chronic hepatitis C infection.
  
  Mr. Higgins has over 25 years of pharmaceutical industry sales and marketing experience.Throughout his career, he has participated in a total of 13 product launches for antiviral, oncology, dermatologic and allergy indications.Prior to joining Roche, Mr. Higgins served in a variety of advertising, sales and marketing roles at Schering Corporation.He was instrumental in developing Schering's Oncology/Biotech group that launched Intron-A(R) (interferon alfa-2b) for the treatment of chronic hepatitis.
  
  "I am delighted to join Pharmasset at this stage of its development," stated Mr. Higgins.
  ...
  Mr. Higgins received his M.B.A. from Seton Hall University and his Bachelor of Arts from Villanova University.

• 
  www.johnlainghomes.com/TheMetroCollection - [Cached Version]
  Published on: 6/19/2008    Last Visited: 6/19/2008  

  "Each member of The Metro Collection boasts an exceptional degree of what we call ,urb appeal,'" said Patrick Higgins, vice president of sales and marketing for John Laing Homes.

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
  Published on: 11/10/2008    Last Visited: 11/10/2008  

  "The combination of oral antiviral therapies for HCV represents an exciting step in the evolution of HCV treatment" stated Patrick Higgins, Executive Vice President of Marketing and Sales at Pharmasset.

• 
  www.hepatitisandhiv.com/hep_c/news/2008/091208_b.html - [Cached Version]
  Published on: 9/8/2008    Last Visited: 9/15/2008  

  Up to 40% of these patients, using SOC in first line therapy for 24 weeks, do not achieve an SVR, which represents an unmet medical need that R7128 has the potential to address," stated Patrick Higgins, Pharmasset's Executive Vice President of Sales and Marketing.

• 
  www.rehabpub.com/press_release.asp?id=10215353 - [Cached Version]
  Published on: 11/10/2008    Last Visited: 11/10/2008  

  "The combination of oral antiviral therapies for HCV represents an exciting step in the evolution of HCV treatment," stated Patrick Higgins
  
  , Executive Vice President of Marketing and Sales at Pharmasset.

• 
  www.rehabpub.com/press_release.asp?id=10215352 - [Cached Version]
  Published on: 11/10/2008    Last Visited: 11/10/2008  

  "The combination of oral antiviral therapies for HCV represents an exciting step in the evolution of HCV treatment" stated Patrick Higgins
  
  , Executive Vice President of Marketing and Sales at Pharmasset.

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/w - [Cached Version]
  Published on: 11/26/2007    Last Visited: 11/27/2007  

  Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & SalesPharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
  ...
  Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
  
  PRINCETON, N.J., Nov. 26 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) appointed Patrick T. Higgins as Executive Vice President, Marketing & Sales, responsible for coordinating the global product launch and marketing activities for Pharmasset's drug candidates.Mr. Higgins, who has served as a consultant to Pharmasset since 2006, was recently Vice President, Sales & Marketing, Virology at Hoffmann-LaRoche, Inc.His areas of expertise include hepatology, HIV and cytomegalovirus for transplant patients.Mr. Higgins was responsible for directing the development and implementation of marketing and sales plans for Roche's US hepatology franchise, including the global launch of Pegasys(R) and Copegus(R) for the treatment of chronic hepatitis C infection.
  
  Mr. Higgins has over 25 years of pharmaceutical industry sales and marketing experience.Throughout his career, he has participated in a total of 13 product launches for antiviral, oncology, dermatologic and allergy indications.Prior to joining Roche, Mr. Higgins served in a variety of advertising, sales and marketing roles at Schering Corporation.He was instrumental in developing Schering's Oncology/Biotech group that launched Intron-A(R) (interferon alfa-2b) for the treatment of chronic hepatitis.
  
  "I am delighted to join Pharmasset at this stage of its development," stated Mr. Higgins.
  ...
  Mr. Higgins received his M.B.A. from Seton Hall University and his

• 
  investor.pharmasset.com/releasedetail.cfm?ReleaseID=276 - [Cached Version]
  Published on: 11/26/2007    Last Visited: 11/25/2008  

  Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
  
  PRINCETON, N.J., Nov 26, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Pharmasset, Inc. (Nasdaq: VRUS) appointed Patrick T. Higgins as Executive Vice President, Marketing & Sales, responsible for coordinating the global product launch and marketing activities for Pharmasset's drug candidates.Mr. Higgins, who has served as a consultant to Pharmasset since 2006, was recently Vice President, Sales & Marketing, Virology at Hoffmann-LaRoche, Inc.His areas of expertise include hepatology, HIV and cytomegalovirus for transplant patients.Mr. Higgins was responsible for directing the development and implementation of marketing and sales plans for Roche's US hepatology franchise, including the global launch of Pegasys(R) and Copegus(R) for the treatment of chronic hepatitis C infection.
  
  Mr. Higgins has over 25 years of pharmaceutical industry sales and marketing experience.Throughout his career, he has participated in a total of 13 product launches for antiviral, oncology, dermatologic and allergy indications.Prior to joining Roche, Mr. Higgins served in a variety of advertising, sales and marketing roles at Schering Corporation.He was instrumental in developing Schering's Oncology/Biotech group that launched Intron-A(R) (interferon alfa-2b) for the treatment of chronic hepatitis.
  
  "I am delighted to join Pharmasset at this stage of its development," stated Mr. Higgins.
  ...
  Mr. Higgins received his M.B.A. from Seton Hall University and his Bachelor of Arts from Villanova University.

• 
  www.ecomresourcesdepot.com/launches/ - [Cached Version]
  Published on: 11/25/2007    Last Visited: 11/26/2007  

  Pharmasset Appoints Patrick T. Higgins as Executive Vice President ... - CNNMoney.com
  
  Pharmasset Appoints Patrick T. Higgins as Executive Vice President ... CNNMoney.com - 2 hours agoThroughout his career, he has participated in a total of 13 product launches for antiviral, oncology, dermatologic and allergy indications. ...

Page:  1 2 3